Home / Companies / SpringWorks Therapeutics, Inc. / 16 May 2024
SpringWorks Therapeutics, Inc.: meeting of 16 May 2024
Votes reported on Form N-PX, item by item
335 Form N-PX filers reported votes at the SpringWorks Therapeutics, Inc. meeting of 16 May 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
1 nominee; 54.1% of reported votes for; 69 filers withheld from or voted against at least one nominee.
258 vote records from 139 filers. 63 of the 138 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
510 vote records from 335 filers. 247 of the 327 filers that marked the item either way voted against management. 8 filers reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
258 vote records from 139 filers. 2 of the 138 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | Against * | For |
| Fidelity | For | For | For |
| Dimensional | Abstain or withhold * | Against * | For |
| State Street and SPDR | Abstain or withhold * | For | For |
| American Century | Abstain or withhold * | Against * | For |
| Invesco | Abstain or withhold * | Against * | For |
| Equitable | For | Against * | For |
| Charles Schwab | For | Against * | For |
| Nuveen and TIAA | For | Against * | For |
| ProShares and ProFunds | Abstain or withhold * | Against * | For |
| John Hancock and Manulife | For | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | Against * | For |
| J.P. Morgan | For | Against * | For |
| Goldman Sachs | Abstain or withhold * | Against * | For |
| PGIM and Prudential | For | Against * | For |
| Jackson National funds | Abstain or withhold * | Against * | For |
| Northern Trust and FlexShares | For | For | For |
| SEI | For | Against * | For |
| T. Rowe Price | For | Against * | For |
| Lincoln Financial | Abstain or withhold * | For | For |
| Voya | Abstain or withhold * | Against * | For |
| First Trust | Abstain or withhold * | Against * | For |
| Russell Investments | For | Against * | For |
| Nationwide | Abstain or withhold * | Against * | For |
| Victory Capital | Abstain or withhold * | Against * | For |
| Brighthouse Funds | For | Against * | For |
| Guggenheim and Rydex | Abstain or withhold * | Against * | For |
| Columbia Threadneedle | For | Against * | For |
| BNY Mellon | Abstain or withhold * | Against * | For |
| Principal | Abstain or withhold * | Against * | For |
| Pacific Life funds | Abstain or withhold * | Against * | For |
| Global X | For | Against * | For |
| MFS | Abstain or withhold * | Against * | For |
| Transamerica | For | Against * | For |
| Federated Hermes | For | Against * | For |
| AllianceBernstein | No report | Against * | No report |
| DWS | Abstain or withhold * | Against * | For |
| Allspring | Abstain or withhold * | Against * | For |
| MassMutual | Abstain or withhold * | Against * | For |
| Janus Henderson | No report | Against * | No report |
| Neuberger Berman | No report | Against * | No report |
| Natixis and Loomis Sayles | No report | Against * | No report |
| Lord Abbett | For | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the SpringWorks Therapeutics, Inc. meeting?
335 Form N-PX filers reported votes at the meeting of 16 May 2024. On say-on-pay, 247 of 327 voted against management (75.5%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by SpringWorks Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for SpringWorks Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing SpringWorks Therapeutics, Inc. with a meeting date within three days of 16 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.